202 related articles for article (PubMed ID: 25891862)
21. Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
O'Brien S; Jones JA; Coutre SE; Mato AR; Hillmen P; Tam C; Österborg A; Siddiqi T; Thirman MJ; Furman RR; Ilhan O; Keating MJ; Call TG; Brown JR; Stevens-Brogan M; Li Y; Clow F; James DF; Chu AD; Hallek M; Stilgenbauer S
Lancet Oncol; 2016 Oct; 17(10):1409-1418. PubMed ID: 27637985
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
[TBL] [Abstract][Full Text] [Related]
23. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
[TBL] [Abstract][Full Text] [Related]
24. Report of two novel chromosomal translocations in chronic lymphocytic leukemia.
Athanasiadou A; Stamatopoulos K; Tsompanakou A; Foutsitsakis D; Fassas A; Anagnostopoulos A; Tsezou A
Leuk Lymphoma; 2005 Jan; 46(1):133-6. PubMed ID: 15621791
[TBL] [Abstract][Full Text] [Related]
25. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
26. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Andreieva SV; Korets KV; Ruzhinska OE; Skorokhod IM; Alkhimova OG
Exp Oncol; 2017 Jul; 39(2):141-144. PubMed ID: 29483496
[TBL] [Abstract][Full Text] [Related]
27. Structural aberrations of chromosomes 17 and 12 in chronic B-cell disorders.
Cerretini R; Chena C; Giere I; Sarmiento M; Arrossagaray G; Rodríguez A; Pérez Bianco R; de Dios Soler M; Narbaitz M; Slavutsky I
Eur J Haematol; 2003 Dec; 71(6):433-8. PubMed ID: 14703693
[TBL] [Abstract][Full Text] [Related]
28. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation.
Cuneo A; Balboni M; Piva N; Rigolin GM; Roberti MG; Mejak C; Moretti S; Bigoni R; Balsamo R; Cavazzini P
Br J Haematol; 1995 Jun; 90(2):409-16. PubMed ID: 7794764
[TBL] [Abstract][Full Text] [Related]
29. Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities.
Jimenez-Zepeda VH; Chng WJ; Schop RF; Braggio E; Leis JF; Kay N; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):467-76. PubMed ID: 23876845
[TBL] [Abstract][Full Text] [Related]
30. A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53.
Shindiapina P; Brown JR; Danilov AV
Br J Haematol; 2014 Oct; 167(2):149-61. PubMed ID: 25040077
[TBL] [Abstract][Full Text] [Related]
31. Clinical implication of chromosomal aberrations in chronic B-lymphocytic leukaemia cells.
Gahrton G; Juliusson G
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):389-92. PubMed ID: 3265508
[TBL] [Abstract][Full Text] [Related]
32. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
[TBL] [Abstract][Full Text] [Related]
33. Japanese B cell chronic lymphocytic leukaemia: a cytogenetic and molecular biological study.
Asou H; Takechi M; Tanaka K; Tashiro S; Dohy H; Ohno R; Kamada N
Br J Haematol; 1993 Nov; 85(3):492-7. PubMed ID: 8136271
[TBL] [Abstract][Full Text] [Related]
34. Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia.
Mould S; Gardiner A; Corcoran M; Oscier DG
Br J Haematol; 1996 Feb; 92(2):389-92. PubMed ID: 8603005
[TBL] [Abstract][Full Text] [Related]
35. Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.
Travella A; Ripollés L; Aventin A; Rodríguez A; Bezares RF; Caballín MR; Slavutsky I
Hematol Oncol; 2013 Jun; 31(2):79-87. PubMed ID: 22961973
[TBL] [Abstract][Full Text] [Related]
36. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
[TBL] [Abstract][Full Text] [Related]
37. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
Blanco G; Puiggros A; Baliakas P; Athanasiadou A; García-Malo M; Collado R; Xochelli A; Rodríguez-Rivera M; Ortega M; Calasanz MJ; Luño E; Vargas M; Grau J; Martínez-Laperche C; Valiente A; Cervera J; Anagnostopoulos A; Gimeno E; Abella E; Stalika E; Hernández-Rivas JM; Ortuño FJ; Robles D; Ferrer A; Ivars D; González M; Bosch F; Abrisqueta P; Stamatopoulos K; Espinet B
Oncotarget; 2016 Dec; 7(49):80916-80924. PubMed ID: 27821812
[TBL] [Abstract][Full Text] [Related]
38. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
[TBL] [Abstract][Full Text] [Related]
39. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.
Farooqui MZ; Valdez J; Martyr S; Aue G; Saba N; Niemann CU; Herman SE; Tian X; Marti G; Soto S; Hughes TE; Jones J; Lipsky A; Pittaluga S; Stetler-Stevenson M; Yuan C; Lee YS; Pedersen LB; Geisler CH; Calvo KR; Arthur DC; Maric I; Childs R; Young NS; Wiestner A
Lancet Oncol; 2015 Feb; 16(2):169-76. PubMed ID: 25555420
[TBL] [Abstract][Full Text] [Related]
40. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
Mayr C; Speicher MR; Kofler DM; Buhmann R; Strehl J; Busch R; Hallek M; Wendtner CM
Blood; 2006 Jan; 107(2):742-51. PubMed ID: 16179374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
